The Challenge with Peptide Therapeutics
Needles required
most peptides can only be given by injection
Low patient compliance
painful, anxiety-inducing, especially with repeated use.
High costs, high waste
cold chain logistics and hazardous sharps drive up expense and environmental burden.
Our Solution
Vitropep’s proprietary molecular glass technology predicts and stabilizes peptides, enabling painless intradermal delivery through dissolvable microneedle patches.
Our Technology
"At Vitropep, we're turning peptide therapeutics into safe, patient-friendly treatments. Our patent-pending platform creates dissolving microneedles optimized for painless delivery, giving partners a versatile tool to bring biomolecules from lab to clinic."
Christophe Tarabout, PhD. Founder, CEO & CTO
At a glance
Painless &
self-administered
Dissolves in minutes, suitable for adults and children.
Scalable & versatile
Works with peptides and small molecules across multiple applications.
Stable at room temperature
Eliminates cold chain requirements.
Patent pending
First applications filed in 2023; manufacturing process patent filed in 2025.
“From our lab to your pipeline: we combine science, creativity, and care to bring peptide candidates to life.”
Why Partner with Vitropep?
Unlock
new possibilities
Adaptable formulations and controlled release for peptides and small molecules.
Boost
patient compliance
Painless, needle-free delivery improves uptake and reduces treatment fatigue.
Cut costs &
complexity
Eliminate refrigeration,
cold chain logistics,
and fragile vials.
Built-in
sustainability
Reduced waste,
green chemistry, and alignment with SDGs 3, 9, and 12.
Vision
We aim to transform peptide therapeutics with innovative, needle-free delivery. Vitropep’s dissolving microneedle platform enables safer, patient-friendly treatments while reducing healthcare complexity and environmental impact. Our goal: partner with innovators to bring breakthrough therapies to patients worldwide.
Mission
Our mission is to accelerate peptide drug development through a scalable, patent-pending microneedle platform. We collaborate with partners to stabilize peptides, streamline delivery, and create tailored solutions that improve patient compliance and therapeutic outcomes, bringing innovative treatments to market faster and more sustainably.
Vitropep is proud to be recognized and supported by
leading biotech and innovation networks.
